SB2886 - Updated Drug Labeling for Patient Safety Act
US Congress - 118th Congress
Last updated about 1 year ago
0 Co-Sponsors
A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now